Cozaar and Reflux oesophagitis - a phase IV clinical study of FDA data

Summary:

Reflux oesophagitis is reported as a side effect among people who take Cozaar (losartan potassium), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Hydrochlorothiazide, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Reflux oesophagitis when taking Cozaar. It is created by eHealthMe based on reports of 43,582 people who have side effects when taking Cozaar from the FDA, and is updated regularly.

What is Cozaar?

Cozaar has active ingredients of losartan potassium. It is often used in high blood pressure. eHealthMe is studying from 45,124 Cozaar users. Check the latest studies of Cozaar.

What is Reflux oesophagitis?

Reflux oesophagitis (an oesophageal mucosal injury that occurs of gastric contents into the oesophagus) is found to be associated with 337 drugs and 570 conditions by eHealthMe. Check the latest studies of Reflux oesophagitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

43,582 people reported to have side effects when taking Cozaar.
Among them, 30 people (0.07%) have Reflux oesophagitis.

Among these 30 people:

How long have people been on Cozaar when they have Reflux oesophagitis? *

What is the gender of people who have Reflux oesophagitis when taking Cozaar? *

female: 36.67 %
male: 63.33 %

What is the age of people who have Reflux oesophagitis when taking Cozaar? *

What are other drugs people take besides Cozaar? *

What are other side effects people have besides Reflux oesophagitis? *

Depression: 19 people, 63.33%
Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall): 18 people, 60.00%
Dyspnea (difficult or laboured breathing): 18 people, 60.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 18 people, 60.00%
Fatigue (feeling of tiredness): 17 people, 56.67%
Cough: 17 people, 56.67%
Dizziness: 17 people, 56.67%
Chest Pain: 17 people, 56.67%
Diarrhea: 17 people, 56.67%
Ventricular Hypertrophy (enlargement of ventricles (lower chambers) in the heart): 17 people, 56.67%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 16 people, 53.33%
Joint Pain: 15 people, 50.00%
High Blood Cholesterol: 15 people, 50.00%
Seborrhoeic Dermatitis (a common, inflammatory skin condition that causes flaky, white to yellowish scales to form on oily areas such as the scalp): 14 people, 46.67%
Diarrhea: 14 people, 46.67%
Fluid Retention (an abnormal accumulation of fluid in the blood): 14 people, 46.67%
Mood Swings (an extreme or rapid change in mood): 14 people, 46.67%
Seasonal Allergy (allergic condition due to certain season): 7 people, 23.33%
Blood Triglycerides Decreased: 7 people, 23.33%
Gastritis (inflammation of stomach): 2 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Cozaar and have Reflux oesophagitis?

- Check whether Reflux oesophagitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cozaar:

Cozaar (45,124 reports)

Browse all side effects of Cozaar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Reflux oesophagitis:

Reflux oesophagitis (337 drugs)

Browse all the conditions that are associated with Reflux oesophagitis:

Reflux oesophagitis (570 conditions)

Related publications that referenced our studies

Lai SW, Lin HF, Lin CL, Liao KF, "No association between losartan use and acute pancreatitis in hypertensive patients", Eur J Hosp Pharm, 2017 Mar .
Lai SW, Lin HF, Lin CL, Liao KF, "No association between losartan use and acute pancreatitis in hypertensive patients", Eur J Hosp Pharm, 2017 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on losartan potassium (the active ingredients of Cozaar) and Cozaar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.